| A noncompeting pair of human neutralizing antibodies block COVID-19 virus binding to its receptor ACE2 Y Wu, F Wang, C Shen, W Peng, D Li, C Zhao, Z Li, S Li, Y Bi, Y Yang, ... Science 368 (6496), 1274-1278, 2020 | 1074 | 2020 |
| An engineered bispecific human monoclonal antibody against SARS-CoV-2 Z Li, S Li, G Zhang, W Peng, Z Chang, X Zhang, Z Fan, Y Chai, F Wang, ... Nature Immunology 23 (3), 423-430, 2022 | 46 | 2022 |
| Overproduction of docosahexaenoic acid in Schizochytrium sp. through genetic engineering of oxidative stress defense pathways X Han, Z Li, Y Wen, Z Chen Biotechnology for Biofuels 14, 1-10, 2021 | 20 | 2021 |
| Defining a de novo non-RBM antibody as RBD-8 and its synergistic rescue of immune-evaded antibodies to neutralize Omicron SARS-CoV-2 X Rao, R Zhao, Z Tong, S Guo, W Peng, K Liu, S Li, L Wu, J Tong, Y Chai, ... Proceedings of the National Academy of Sciences 120 (52), e2314193120, 2023 | 4 | 2023 |
| Function and mechanism of bispecific antibodies targeting SARS-CoV-2 Z Li, Z Zhang, ST Rosen, M Feng Cell Insight, 100150, 2024 | | 2024 |
